XSHE
300801
Market cap861mUSD
Jul 10, Last price
26.00CNY
1D
-2.77%
1Q
-2.15%
IPO
-2.86%
Name
Shandong Taihe Technology Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Shandong Taihe Water Treatment Technologies Co., Ltd. focuses on the research, production, and sale of a wide array of chemicals designed for water treatment. Their product line encompasses various phosphonate-based solutions, such as antiscalants, corrosion inhibitors, and chelating agents, along with their corresponding salts. The company also offers polycarboxylic and biodegradable antiscalants and dispersants, biocides, algicides, and combined scale and corrosion inhibitors, including pretreatment filming agents. Additional specialized products include oxygen scavengers and reverse osmosis chemicals. These solutions are vital in numerous applications, ranging from industrial circulating cooling water systems in sectors like electricity, metallurgy, and petrochemicals, to reverse osmosis processes for seawater desalination and pure water generation. Furthermore, their chemicals are utilized in oil extraction, household products, textile and dyeing, paper and pulp manufacturing, ceramics, coatings, electronic cleaning, sugar production, aquaculture, and agriculture. Founded in 2006, the company is headquartered in Zaozhuang, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||